Abstract
Along with the comprehensive data concerning our institutional experience on the use of rituximab for treatment of non-Hodgkin's lymphoma, we describe the first case of molecular remission induced by the chimeric anti-CD20 monoclonal antibody in a diffuse large cell lymphoma patient.
| Original language | English |
|---|---|
| Pages (from-to) | 437-438 |
| Number of pages | 2 |
| Journal | Haematologica |
| Volume | 85 |
| Issue number | 4 |
| Publication status | Published - 2000 |
Fingerprint
Keywords
- Aggressive lymphoma
- Molecular remission
- Rituximab
ASJC Scopus subject areas
- Hematology
Cite this
Zinzani, P. L., Bendandi, M., Gamberi, B., Magagnoli, M., Gherlinzoni, F., & Tura, S. (2000). Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma. Haematologica, 85(4), 437-438.